-
Senate Democrats’ support for single-payer healthcare grows
Seth Sandronsky Healthcare AdministrationOn Sept. 13, Sen. Bernie Sanders (I-Vt.) introduced his Medicare for All Act of 2017, which has the support of 16 Senate Democrats so far. His bill would extend Medicare — the health insurance program for Americans age 65 and up — to the entire U.S. population, phased in over a four-year period.
-
FDA turns attention to children’s medicine in battle against opioids
Dr. Abimbola Farinde PharmaceuticalThe opioid epidemic in America is one that has clearly demonstrated its far-reaching impact regardless of the background of the individuals who find themselves abusing this class of drugs. Within recent months, the opioid crisis has reached the level of being recognized as "a national emergency" by President Donald Trump.
-
Pharmacists should take notice of new back pain guidelines
Jason Poquette PharmaceuticalPharmacists — particularly those working on the front lines of community pharmacy — may want to think about the latest guidelines for treating lower back pain (LBP). These guidelines were developed by the American College of Physicians (ACP) and published in the most recent edition of the Journal of the American Medical Association (JAMA).
-
DEA steps in to help curb opioid crisis
Dr. Abimbola Farinde PharmaceuticalThe use of opioids in the United States has reached a point at which it is now considered to be a major public health concern due to the alarming rates of overdose and death. President Donald Trump also recognizes that the opioid crisis is one that requires immediate attention and focus in order to prevent future deaths.
-
Lessons for pharmacists from a sexual coercion case
Jason Poquette PharmaceuticalThe racy details of a recent accusation against an 81-year-old pharmacist are getting a lot of attention in the media. According to the alleged victim, the pharmacist forced her to remove her clothing in front of him in exchange for filling her prescription for Oxycontin. The pharmacist, Robert Kenzia, is the owner of MacLeod's Drugs in Niagara Falls, New York. Apparently, the police found the evidence convincing enough to arrest him.
-
Ohio study examines effectiveness of opioid guidelines
Scott G. Weiner Medical & Allied HealthcareIn the face of the ongoing tragedy of the current U.S. opioid epidemic, multiple groups are attempting to create guidelines that influence opioid prescribing behavior. From hospitals to state governments, from the CDC to physician specialty societies, guidelines are being produced, as they are easy and inexpensive to create and don't require legislation or enforcement.
-
States starting to respond to gabapentin abuse
Jason Poquette PharmaceuticalSeveral states around the country have started to respond to a yet another growing problem: gabapentin abuse. Over the past several years, a series of reports and studies have confirmed that patients are using high doses of gabapentin for recreational purposes. The same types of drug-seeking behaviors, euphoria and even withdrawal symptoms are exhibited that have traditionally been associated with controlled substances.
-
Charcoal treats: Latest food fad may black out medications’ properties
Katherine Radin Food & BeverageOver-the-top ice cream cones, rainbow bagels, unicorn Frappuccinos ... Every few months, a new food fad hits, prompting diners to share bright photos of the latest treat on their social media feeds.
-
McCain’s surprise vote kills ACA ‘skinny repeal’
Seth Sandronsky Healthcare AdministrationThe Republican Party's bid to overturn the Affordable Care Act ended with a whimper early Friday morning when Sen. John McCain cast the key no vote.
-
FDA draft Guidance on new dietary ingredients: Do you need to file?
Amy Scanlin PharmaceuticalThe August 2016 draft Guidance on new dietary ingredients (NDIs) broadened the definition of what the FDA considers an NDI, leading many manufacturers to wonder if they should submit notifications for products they've had on the market for years. This article explains the issues and discusses steps manufacturers should take to avoid FDA action.
All Pharmaceutical Articles